Automated discovery of noncovalent inhibitors of SARS-CoV-2 main protease by consensus Deep Docking of 40 billion small molecules

This journal is © The Royal Society of Chemistry..

Recent explosive growth of 'make-on-demand' chemical libraries brought unprecedented opportunities but also significant challenges to the field of computer-aided drug discovery. To address this expansion of the accessible chemical universe, molecular docking needs to accurately rank billions of chemical structures, calling for the development of automated hit-selecting protocols to minimize human intervention and error. Herein, we report the development of an artificial intelligence-driven virtual screening pipeline that utilizes Deep Docking with Autodock GPU, Glide SP, FRED, ICM and QuickVina2 programs to screen 40 billion molecules against SARS-CoV-2 main protease (Mpro). This campaign returned a significant number of experimentally confirmed inhibitors of Mpro enzyme, and also enabled to benchmark the performance of twenty-eight hit-selecting strategies of various degrees of stringency and automation. These findings provide new starting scaffolds for hit-to-lead optimization campaigns against Mpro and encourage the development of fully automated end-to-end drug discovery protocols integrating machine learning and human expertise.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Chemical science - 12(2021), 48 vom: 15. Dez., Seite 15960-15974

Sprache:

Englisch

Beteiligte Personen:

Gentile, Francesco [VerfasserIn]
Fernandez, Michael [VerfasserIn]
Ban, Fuqiang [VerfasserIn]
Ton, Anh-Tien [VerfasserIn]
Mslati, Hazem [VerfasserIn]
Perez, Carl F [VerfasserIn]
Leblanc, Eric [VerfasserIn]
Yaacoub, Jean Charle [VerfasserIn]
Gleave, James [VerfasserIn]
Stern, Abraham [VerfasserIn]
Wong, Bill [VerfasserIn]
Jean, François [VerfasserIn]
Strynadka, Natalie [VerfasserIn]
Cherkasov, Artem [VerfasserIn]

Links:

Volltext

Themen:

Journal Article

Anmerkungen:

Date Revised 21.09.2023

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1039/d1sc05579h

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM33558991X